Abstract
This paper presents the architecture of the electronic detection and data processing (analysis) part, of a Lab-on- Chip (LoC) device. The data processing part focuses on the analysis of signals captured from the sensors used to detect possible mutations in the sample under consideration. The LoC consists of a micro-fluidics part for the sample preparation and hybridization, a micro-system part including the sensors for the hybridization electronic detection and finally a processing part for the data analysis and an interface for results presentation. The use of such LoCs aims at identifying the appropriate cluster of patients for a pharmacogenomic medicine based on the gene analysis results and at optimizing the effectiveness of the drug or determining whether the affected patient belongs to a group of patients who would suffer severe side effects.
Keywords: Lab-on-chip, embedded system, multi-core SoC, microarray, sensor signal processing, pharmacogenomics
Micro and Nanosystems
Title: Lab-on-Chip for Pharmacogenomics: An Embedded System Organization
Volume: 1 Issue: 1
Author(s): George Kornaros, Athanasios Demiris and Spyros Blionas
Affiliation:
Keywords: Lab-on-chip, embedded system, multi-core SoC, microarray, sensor signal processing, pharmacogenomics
Abstract: This paper presents the architecture of the electronic detection and data processing (analysis) part, of a Lab-on- Chip (LoC) device. The data processing part focuses on the analysis of signals captured from the sensors used to detect possible mutations in the sample under consideration. The LoC consists of a micro-fluidics part for the sample preparation and hybridization, a micro-system part including the sensors for the hybridization electronic detection and finally a processing part for the data analysis and an interface for results presentation. The use of such LoCs aims at identifying the appropriate cluster of patients for a pharmacogenomic medicine based on the gene analysis results and at optimizing the effectiveness of the drug or determining whether the affected patient belongs to a group of patients who would suffer severe side effects.
Export Options
About this article
Cite this article as:
Kornaros George, Demiris Athanasios and Blionas Spyros, Lab-on-Chip for Pharmacogenomics: An Embedded System Organization, Micro and Nanosystems 2009; 1 (1) . https://dx.doi.org/10.2174/1876402910901010030
DOI https://dx.doi.org/10.2174/1876402910901010030 |
Print ISSN 1876-4029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-4037 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Progress of Epilepsy after Stroke
Current Neuropharmacology From Bone to Brain: Human Skeletal Stem Cell Therapy for Stroke
Central Nervous System Agents in Medicinal Chemistry Colon Targeted Press Coated Tablets of Venlafaxine Hydrochloride for Treatment of Depression
Current Psychopharmacology Renal Heat Shock Proteins Over-Expression Due to Anabolic Androgenic Steroids Abuse
Mini-Reviews in Medicinal Chemistry Multiple-Dose Pharmacokinetics of Efavirenz with and without the Use of Rifampicin in HIV-Positive Patients
Current HIV Research Body-centred and Object-centred Motor Imagery in Alzheimer's Disease
Current Alzheimer Research Genetic Dissection of Complex Traits In Silico: Approaches, Problems and Solutions
Current Bioinformatics Brain and Quantum Dots: Benefits of Nanotechnology for Healthy and Diseased Brain
Central Nervous System Agents in Medicinal Chemistry Suicide Risk in Obsessive-Compulsive Disorder and Exploration of Risk Factors: A Systematic Review
Current Neuropharmacology Alcoholism, Personality, and Religion/Spirituality: An Integrative Review
Current Drug Abuse Reviews Meet Our Editorial Board Member
Current Radiopharmaceuticals Binding Site Detection and Druggability Prediction of Protein Targets for Structure- Based Drug Design
Current Pharmaceutical Design What Metabolic Syndrome Contributes to Brain Outcomes in African American & Caucasian Cohorts
Current Alzheimer Research Psycho-Cognitive Intervention for ASD from Cross-Species Behavioral Analyses of Infants, Chicks and Common Marmosets
CNS & Neurological Disorders - Drug Targets Development of Peptides as Potential Drugs for Cancer Therapy
Current Pharmaceutical Design Intracellular Signaling by Phospholipase D as a Therapeutic Target
Current Pharmaceutical Biotechnology The Role of Microbial Agents in the Etiology of Schizophrenia: An Infectious Hypothesis for Psychosis?
Current Immunology Reviews (Discontinued) Obesity and Arterial Compliance Alterations
Current Vascular Pharmacology Computational Biology Tools for Identifying Specific Ligand Binding Residues for Novel Agrochemical and Drug Design
Current Protein & Peptide Science The Structure and Main Functions of Aminopeptidase N
Current Medicinal Chemistry